Stephen Opat
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 88
- Genetics 88
- Chronic Lymphocytic Leukemia Research 84
- Co-authors
- Constantine S. Tam (63 shared papers)John F. Seymour (20 shared papers)Judith Trotman (31 shared papers)Carolyn Owen (3 shared papers)Michael Wenger (3 shared papers)Marek Trněný (3 shared papers)Robert Marcus (3 shared papers)Wolfgang Hiddemann (2 shared papers)
- Journals
- Blood (51 papers)Hematological Oncology (13 papers)Blood Advances (11 papers)HemaSphere (11 papers)Journal of Clinical Oncology (9 papers)
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
Stephen Opat
146 papers receiving 2.9k citations
Stephen Opat's Hit Papers
Peers
Comparison fields: 5 of 81
- Genetics 1.3k
- Pathology and Forensic Medicine 1.6k
- Hematology 537
- Oncology 887
- Immunology 500
Countries citing papers authored by Stephen Opat
This map shows the geographic impact of Stephen Opat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Opat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Opat more than expected).
Fields of papers citing papers by Stephen Opat
This network shows the impact of papers produced by Stephen Opat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Opat. The network helps show where Stephen Opat may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Opat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obinutuzumab for the First-Line Treatment of Follicular Lymphoma Hit paper breakdown → | 2017 | 494 |
| 2 | 2011 | 251 | |
| 3 | Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort Hit paper breakdown → | 2022 | 140 |
| 4 | 2021 | 114 | |
| 5 | 2015 | 99 | |
| 6 | 2014 | 94 | |
| 7 | 2007 | 93 | |
| 8 | 2001 | 92 | |
| 9 | 2018 | 88 | |
| 10 | 2020 | 80 | |
| 11 | 2021 | 68 | |
| 12 | 2013 | 56 | |
| 13 | 2016 | 52 | |
| 14 | 2012 | 51 | |
| 15 | 2021 | 46 | |
| 16 | 2016 | 35 | |
| 17 | 2020 | 32 | |
| 18 | 2013 | 31 | |
| 19 | 2019 | 31 | |
| 20 | 2022 | 30 |
About Stephen Opat
Stephen Opat is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Immunology, having authored 166 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (88 papers), Chronic Lymphocytic Leukemia Research (84 papers), Chronic Myeloid Leukemia Treatments (19 papers), Immunodeficiency and Autoimmune Disorders (17 papers), Viral-associated cancers and disorders (14 papers), Acute Lymphoblastic Leukemia research (13 papers), CNS Lymphoma Diagnosis and Treatment (10 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Genetics (1.3k citations), Pathology and Forensic Medicine (1.6k citations), Hematology (537 citations), Oncology (887 citations) and Immunology (500 citations). Stephen Opat has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Constantine S. Tam, John F. Seymour, Judith Trotman, Carolyn Owen, Michael Wenger, Marek Trněný, Robert Marcus, Wolfgang Hiddemann, Kiyoshi Ando and Andrew Davies. Their work appears in journals such as Blood, Hematological Oncology, Blood Advances, HemaSphere and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.